Itau Unibanco Holding SA (ADR) (NYSE:ITUB) begin trading ex-dividend on February 02, 2015. A cash dividend payment of $0.005737 per share is scheduled to be paid on March 12, 2015. On Wednesday shares of Itau Unibanco Holding SA (ADR) (NYSE:ITUB) closed at $12.94. Company’s sales growth for last 5 years was 14.60% and EPS growth for next 5 years is recorded as 17.50%.
On Feb 02, Hemispherx Biopharma, Inc. (NYSE:HEB) announced the results of a new efficacy study of Ampligen® in a mouse model of Ebola virus (EBOV) infection performed by scientists at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID). Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity decreased -13.46% to close at $0.22. Company weekly performance is 2.27% while its quarterly performance stands at -25.00%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) is -54.08% away from its 52 week high.
On Jan 27, Spectranetics Corporation (NASDAQ:SPNC) announced it has completed the acquisition of Covidien’s Stellarex™ drug coated balloon angioplasty (DCB) platform. The transaction closed after the acquisition of Covidien by Medtronic. On last trading day The Spectranetics Corporation (NASDAQ:SPNC) moved up 1.43% to close at $33.28. Its volatility for the week is 3.65% while volatility for the month is 3.33%. SPNC’s sales growth for past 5 years was 8.80% and its EPS growth for past 5 years was 39.20%. The Spectranetics Corporation (NASDAQ:SPNC) monthly performance is -1.07%.
Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for XELJANZ (tofacitinib citrate) 5 mg and 10 mg tablets, a Janus kinase (JAK) inhibitor, the first in a new class of oral medicines being investigated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. On Wednesday shares of Pfizer Inc. (NYSE:PFE) closed at $32.07. Company’s sales growth for last 5 years was 1.30% and EPS growth for next 5 years is recorded as 2.39%.
On Jan. 21, Forward Industries, Inc. (NASDAQ:FORD) announced a leadership transition under which, effective January 15, 2015, Robert Garrett, Jr. voluntarily resigned as Chief Executive Officer. Current director Michael Luetkemeyer will serve as the Company’s interim CEO, effective immediately. In addition, the Board of Directors has also determined to elect Terence Bernard Wise as Chairman of the Company. On last trading day Forward Industries Inc. (NASDAQ:FORD) decreased -1.04% to close at $0.95. Its volatility for the week is 3.56% while volatility for the month is 8.31%. FORD’s sales growth for past 5 years was 13.90% and its EPS growth for past 5 years was 15.00%. Forward Industries Inc. (NASDAQ:FORD) monthly performance is -14.41%.